Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical (LFCR) Consolidated Net Income: 2009-2025

Historic Consolidated Net Income for Lifecore Biomedical (LFCR) over the last 16 years, with May 2025 value amounting to -$1.1 million.

  • Lifecore Biomedical's Consolidated Net Income fell 38333.33% to -$1.1 million in Q2 2025 from the same period last year, while for May 2025 it was -$38.7 million, marking a year-over-year decrease of 1543.59%. This contributed to the annual value of -$38.7 million for FY2025, which is 1543.59% down from last year.
  • Per Lifecore Biomedical's latest filing, its Consolidated Net Income stood at -$1.1 million for Q2 2025, which was up 92.23% from -$14.8 million recorded in Q1 2025.
  • In the past 5 years, Lifecore Biomedical's Consolidated Net Income ranged from a high of $1.9 million in Q3 2023 and a low of -$51.6 million during Q2 2022.
  • Moreover, its 3-year median value for Consolidated Net Income was -$1.7 million (2023), whereas its average is -$6.3 million.
  • Per our database at Business Quant, Lifecore Biomedical's Consolidated Net Income spiked by 143.58% in 2023 and then plummeted by 38,333.33% in 2025.
  • Quarterly analysis of 5 years shows Lifecore Biomedical's Consolidated Net Income stood at -$46.0 million in 2021, then skyrocketed by 92.17% to -$3.6 million in 2022, then skyrocketed by 99.33% to -$24,000 in 2023, then crashed by 27,279.17% to -$6.6 million in 2024, then crashed by 38,333.33% to -$1.1 million in 2025.
  • Its last three reported values are -$1.1 million in Q2 2025, -$14.8 million for Q1 2025, and -$6.6 million during Q4 2024.